Oncology Medications

LONSURF

LONSURF® (trifluridine and tipiracil) Is Available For Order

This limited distribution medication is only available from a select number of pharmacies nationwide.

Ordering LONSURF From Onco360

3 easy ways to order.

Fax

Download the Oral Rx Oncology Order Form
and fax it to 877-662-6355.

Oral Order Form

Call

Call 877-662-6633.

e-Prescribe

e-Prescribe to Onco360 in Great Neck, NY 11021, or NPI# 1679618151 under the retail tab in your EMR/EHR or standalone e-prescribing application.

LONSURF Indication

LONSURF is a limited distribution oral cancer medication just approved by the F.D.A. for patients with an advanced form of colorectal cancer who are no longer responding to other therapies.

APPROVED INDICATION1 RECOMMENDED DOSAGE1
LONSURF is a combination of trifluridine, a nucleoside metabolic inhibitor, and tipiracil, a thymidine phosphorylase inhibitor, indicated for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.
Recommended dose: 35 mg/m2/dose orally twice daily on Days 1 through 5 and Days 8 through 12 of each 28-day cycle.  Take LONSURF within 1 hour after completion of morning and evening meals.

According to the American Cancer Society, approximately 136,830 people will be diagnosed with mCRC in the United States annually, a subset of which will become candidates for treatment with LONSURF2.

 

Reference:

  1. www.taihooncology.com/us/prescribing-information.pdf
  2. Cancer facts & figures 2014. American Cancer Society.

All rights in the product names, trade names, or logos of all third-party products, whether or not appearing with the registered trademark symbol, belong exclusively to their respective owners.